| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/26/2006 | EP1682666A1 Hiv pharmaccines |
| 07/26/2006 | EP1682665A2 Use of fibroblast growth factor fragments |
| 07/26/2006 | EP1682664A2 Methods for the production of apolipoproteins in transgenic plants |
| 07/26/2006 | EP1682663A2 The use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases |
| 07/26/2006 | EP1682658A2 Enzymatic synthesis, modification and decomposition of silicon(iv) compounds and other metal(iv) compounds |
| 07/26/2006 | EP1682655A1 Carbohydrate-binding modules of a new family |
| 07/26/2006 | EP1682653A2 Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them |
| 07/26/2006 | EP1682578A1 Peptide-based immunization therapy for treatment of atherosclerosis |
| 07/26/2006 | EP1682577A2 Novel cell-based assays employing voltage and calcium dyes |
| 07/26/2006 | EP1682576A1 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof |
| 07/26/2006 | EP1682575A1 Igf-i responsive gene and use thereof |
| 07/26/2006 | EP1682574A2 The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases |
| 07/26/2006 | EP1682573A2 The use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferattive diseases |
| 07/26/2006 | EP1682572A1 Protein expression |
| 07/26/2006 | EP1682571A1 A bidentate motif and methods of use |
| 07/26/2006 | EP1682570A1 A binding motif and methods of regulating cell function |
| 07/26/2006 | EP1682569A2 Cellular membrane protein assay |
| 07/26/2006 | EP1682184A1 Stable pharmaceutical composition comprising granulocyte-colony stimulating factor |
| 07/26/2006 | EP1682174A2 Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same |
| 07/26/2006 | EP1682164A2 Cytokine antagonist molecules |
| 07/26/2006 | EP1682106A2 Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes |
| 07/26/2006 | EP1682074A2 Compositions and methods for healthy pregnancy |
| 07/26/2006 | EP1681988A2 Method for diagnosis and treatment of pulmonary disorders |
| 07/26/2006 | EP1573314A4 Transgenic mice expressing human cd20 |
| 07/26/2006 | EP1481065B1 Method for detection of leptin receptor ligands |
| 07/26/2006 | EP1465921B1 Corticotropin releasing factor receptor 2 agonists |
| 07/26/2006 | EP1463830A4 Method for classification of anti-psychotic drugs |
| 07/26/2006 | EP1449917B1 Process for producing l-amino acid using escherichia |
| 07/26/2006 | EP1390543B1 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 07/26/2006 | EP1381686B1 Inactivation of genes of the mep pathway |
| 07/26/2006 | EP1353687B1 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 07/26/2006 | EP1351703B1 Use of a polypeptide comprising the extracellular domains of il-20ra and il-20rb for the treatment of inflammation |
| 07/26/2006 | EP1311297B1 A method for reducing stress-induced overproduction of neuropeptide y in an individual |
| 07/26/2006 | EP1263784B1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 07/26/2006 | EP1257297B1 Compositions and methods for treatemnt of angiogenesis in pathological lesions |
| 07/26/2006 | EP1208216B1 Fatty acid desaturase gene from plants |
| 07/26/2006 | EP1104439B1 Method for producing biostatin (tt-232 triacetate) and analogs thereof |
| 07/26/2006 | EP1078088B1 Transgenic plants with a modified activity of a plastidial adp/atp translocator |
| 07/26/2006 | EP1075517B1 Chimeric receptors |
| 07/26/2006 | EP0934424B1 A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium |
| 07/26/2006 | EP0870199B1 Assays for growth hormone secretagogue receptors |
| 07/26/2006 | EP0859849B1 POLYPEPTIDES AND POLYNUCLEOTIDES RELATING TO THE ALPHA- and BETA-SUBUNITS OF GLUTAMATE DEHYDROGENASES AND METHODS OF USE |
| 07/26/2006 | EP0856058B1 Cell-cycle checkpoint genes |
| 07/26/2006 | EP0832222B1 Linc-53 from c. elegans and its uses in listing compounds involved in the control of cell behaviour and pharmaceutical compositions |
| 07/26/2006 | EP0758396B1 Feline immunodeficiency virus vaccine |
| 07/26/2006 | EP0702694B1 PSEUDOMONAS SYRINGAE pv. SYRINGAE hrpZ GENE |
| 07/26/2006 | EP0637968B2 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING |
| 07/26/2006 | CN1809640A Methods and means for delaying seed shattering in plants |
| 07/26/2006 | CN1809638A Method of detecting beta 3 adrenaline receptor mutant gene and nucleic acid probe and kit therefor |
| 07/26/2006 | CN1809633A Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
| 07/26/2006 | CN1809631A Production of pantothenate using microorganisms incapable of sporulation |
| 07/26/2006 | CN1809590A Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 07/26/2006 | CN1809589A GITR ligand and GITR ligand-related molecules and antibodies and uses thereof |
| 07/26/2006 | CN1809588A A novel method of modulating bone-realted activity |
| 07/26/2006 | CN1809587A Materials and methods relating to g-protein coupled receptor oligomers |
| 07/26/2006 | CN1809584A Compositions comprising cationic microparticles and HCV E1E2 DNA and methods of use thereof |
| 07/26/2006 | CN1809383A Recombinant IL-9 antibodies and uses thereof |
| 07/26/2006 | CN1809381A HIV-1 envelope glycoproteins having unusual disulfide structure |
| 07/26/2006 | CN1809380A Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages |
| 07/26/2006 | CN1809374A Proton-sensing G-protein coupled receptors and DNA sequences thereof |
| 07/26/2006 | CN1807633A Bacillus fungus-suppressing peptide expression regulating gene yxlC |
| 07/26/2006 | CN1807628A Wheat salt-resistant gene |
| 07/26/2006 | CN1807627A Barbadosnut salt induced transcription factor and its coding gene and uses |
| 07/26/2006 | CN1807626A Rice cell cycle protein dependent kinase inhibitor gene |
| 07/26/2006 | CN1807624A HEscFv gene sequence with plant favored codon |
| 07/26/2006 | CN1807623A Positive regulation gene for cell cycle and its coded protein and uses |
| 07/26/2006 | CN1807459A Activated collagen protein stent material and its special restoration factor for binding |
| 07/26/2006 | CN1807458A Activated collagen bone restoration material and its special bone restoration factor for bone binding |
| 07/26/2006 | CN1807456A Recombinant human parathormone PTH1-34 preparation method |
| 07/26/2006 | CN1807455A Breast cancer related gene DREE, its coded protein and uses |
| 07/26/2006 | CN1807454A GIBC gene and its coded protein and uses |
| 07/26/2006 | CN1807453A Bacterial leaf spot resistance related protein and its coding gene and uses |
| 07/26/2006 | CN1807452A Helicobacter Pylori urease B subunit Th epitope peptide, its coding DNA, vaccine and uses |
| 07/26/2006 | CN1807451A ZIBC gene and its coded protein and uses |
| 07/26/2006 | CN1807450A SIP gene and its coded protein and uses |
| 07/26/2006 | CN1807449A BIM apoptosis effect minimum core sequence and its preparation and uses |
| 07/26/2006 | CN1266282C DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences |
| 07/26/2006 | CN1266163C Cotton verticillium wilt germ secreted exciton gene and its application |
| 07/26/2006 | CN1265839C Glycoconjugates obtained from i(candide Utilis) cells and i(Ricinus)i(communis) seeds |
| 07/25/2006 | US7081568 Herbicide resistant plant |
| 07/25/2006 | US7081565 Plant seed specific promoters |
| 07/25/2006 | US7081562 obtained by backcrossing a mouse whose function of immunoglobulin Fc gamma receptor IIB gene is deficient on its chromosome and a wild-type collagen-induced arthritis-susceptible DBA/1J mouse six times or more |
| 07/25/2006 | US7081561 Gene-targeted animal model of apolipoprotein E4 domain interaction and uses thereof |
| 07/25/2006 | US7081529 Recombinant vaccine against botulinum neurotoxin |
| 07/25/2006 | US7081528 An isolated nucleic acid molecule which encodes a T-cell derived inducible factor (TIFS), the complementary sequence of which hybridizes, under stringent conditions, to a specific nucleotide sequence |
| 07/25/2006 | US7081523 And stimulate erythropoiesis; teatment of anemia |
| 07/25/2006 | US7081521 Anti-PRO788 antibodies |
| 07/25/2006 | US7081520 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 07/25/2006 | US7081517 Nucleotide sequences coding for use in detection of mamary gland cancer |
| 07/25/2006 | US7081516 Methods for categorizing patients |
| 07/25/2006 | US7081515 For therapy of patients suffering from deficiencies in the regulation of expression of the CIDE B gene |
| 07/25/2006 | US7081513 Peptides having Chemotaxis Inhibitory Protein from Staphylococcus aureus (CHIPS) activity for diagnosis, prophylaxis and treatment of inflammation and HIV |
| 07/25/2006 | US7081446 Long-acting follicle stimulating hormone analogues and uses thereof |
| 07/25/2006 | US7081444 an octapeptide that selectively activates the Receptors for Activated C-Kinase (RACK) in cardiomyocytes and is linked to a tat-peptide or polyarginine peptide; peptide can be administered before, during or after the ischemic or hypoxic event; antiischemic, antihypoxic agents |
| 07/25/2006 | US7081443 A fusion proteins comprising a cyclic peptide linked to a receptor as a cell growth factors, promoting cell proliferation, cell antiproliferative agents; soluble, potent |
| 07/25/2006 | US7081363 Plant growth regulators; inserting genes; genetic engineering |
| 07/25/2006 | US7081360 Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties |
| 07/25/2006 | US7081354 Interleukin and albumin fusion protein |
| 07/25/2006 | US7081346 Contacting complex comprising receptor and quinoxaline derivative ligand bound thereto with test compound, yielding a receptor-test compound complex and free quinoxaline derivative and measuring amount of free quinoxaline derivative generated |
| 07/25/2006 | US7081345 For use in diagnostic, prognostic, prophylactic or therapeutic formulation |